Kane Biotech Inc. (CVE:KNE – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as C$0.03 and last traded at C$0.03, with a volume of 40245 shares traded. The stock had previously closed at C$0.04.
Kane Biotech Trading Down 14.3%
The stock has a market cap of C$4.99 million, a price-to-earnings ratio of -0.33 and a beta of 0.23. The company has a quick ratio of 0.39, a current ratio of 0.80 and a debt-to-equity ratio of -331.42. The business has a 50-day moving average of C$0.04 and a 200-day moving average of C$0.04.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Recommended Stories
- Five stocks we like better than Kane Biotech
- What is a Death Cross in Stocks?
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- 3 Dividend Kings To Consider
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
